HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Samuel Waxman Selected Research

Aligeron (AS 2)

8/2008Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
2/2005Glutathione-S-transferase pi inhibits As2O3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolism.
5/2004JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells.
4/2004All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.
4/2003Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Samuel Waxman Research Topics

Disease

31Neoplasms (Cancer)
02/2022 - 07/2002
22Acute Promyelocytic Leukemia
03/2016 - 01/2002
10Leukemia
12/2012 - 02/2002
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2022 - 09/2005
7Sudden Infant Death (SID)
02/2022 - 06/2010
7Breast Neoplasms (Breast Cancer)
01/2022 - 08/2002
5Hematologic Neoplasms (Hematological Malignancy)
12/2006 - 01/2002
4Carcinogenesis
07/2016 - 01/2005
4Lymphoma (Lymphomas)
12/2012 - 04/2003
4Carcinoma (Carcinomatosis)
02/2011 - 01/2005
4Multiple Myeloma
03/2008 - 01/2002
3Hepatocellular Carcinoma (Hepatoma)
05/2011 - 12/2008
2B-Cell Lymphoma (Lymphoma, B Cell)
04/2022 - 12/2012
2Triple Negative Breast Neoplasms
07/2016 - 08/2015
2Inflammation (Inflammations)
04/2015 - 04/2013
2Myeloid Leukemia (Leukemia, Myelocytic)
12/2012 - 03/2005
2Melanoma (Melanoma, Malignant)
01/2005 - 12/2003
2Prostatic Neoplasms (Prostate Cancer)
05/2004 - 12/2003
1Chromosome Aberrations (Chromosome Abnormalities)
01/2017
1Necrosis
06/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2011
1Lung Neoplasms (Lung Cancer)
06/2011
1Progressive Multifocal Leukoencephalopathy
03/2009

Drug/Important Bio-Agent (IBA)

18Arsenic Trioxide (Trisenox)FDA Link
01/2018 - 01/2002
15Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2022 - 02/2002
12Proteins (Proteins, Gene)FDA Link
02/2022 - 08/2002
5Retinoic Acid Receptor alphaIBA
03/2009 - 02/2002
5Aligeron (AS 2)IBA
08/2008 - 04/2003
4Transcription Factors (Transcription Factor)IBA
01/2022 - 12/2006
4ChromatinIBA
01/2022 - 03/2008
4Peptides (Polypeptides)IBA
01/2022 - 08/2015
4RetinoidsIBA
07/2016 - 10/2003
4TamoxifenFDA LinkGeneric
08/2015 - 02/2008
4Co-Repressor ProteinsIBA
08/2015 - 05/2003
4Histone Deacetylase InhibitorsIBA
03/2007 - 08/2002
4promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
09/2005 - 08/2002
3CytokinesIBA
04/2015 - 01/2005
3Cyclin D1IBA
06/2011 - 09/2006
3ArsenicIBA
03/2009 - 07/2002
2retinoic acid receptor betaIBA
01/2022 - 06/2010
2Histone Deacetylases (Histone Deacetylase)IBA
01/2022 - 08/2002
2Estrogens (Estrogen)FDA Link
08/2015 - 04/2011
2Therapeutic UsesIBA
12/2012 - 05/2005
2Caspase 3 (Caspase-3)IBA
12/2012 - 03/2005
2Caspase 8 (Caspase-8)IBA
11/2012 - 03/2005
2CyclinsIBA
02/2008 - 09/2006
2UbiquitinIBA
05/2007 - 12/2006
2Bortezomib (Velcade)FDA Link
05/2007 - 09/2006
2Proteasome Endopeptidase Complex (Proteasome)IBA
05/2007 - 12/2006
2Proteasome InhibitorsIBA
05/2007 - 09/2006
2Death Domain ReceptorsIBA
12/2006 - 03/2005
2Glutathione S-Transferase piIBA
02/2005 - 05/2004
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2005 - 12/2003
2InterleukinsIBA
01/2005 - 12/2003
2Butyric Acid (Butanoic Acid)IBA
10/2003 - 08/2002
1Cytarabine (Cytosar-U)FDA LinkGeneric
04/2022
1venetoclaxIBA
04/2022
1Checkpoint Kinase 1IBA
04/2022
1LuciferasesIBA
01/2022
1Am 580 (Am580)IBA
01/2022
1Biological ProductsIBA
09/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2018
1Sorafenib (BAY 43-9006)FDA Link
01/2018
1CateninsIBA
10/2017
1B7-H1 AntigenIBA
01/2017
1tamibaroteneIBA
07/2016
1A-factor (Streptomyces)IBA
10/2015
1Ivermectin (Mectizan)FDA Link
08/2015
1avermectinIBA
08/2015
1ProgesteroneFDA LinkGeneric
08/2015
1selamectinIBA
08/2015
1TOR Serine-Threonine KinasesIBA
04/2015
1IronIBA
03/2015
1Apoptosis Regulatory ProteinsIBA
03/2015
1artenimol (dihydroartemisinin)IBA
03/2015
1Cytochromes c (Cytochrome c)IBA
12/2012
1ethacrynic acid butyl esterIBA
12/2012
1Ethacrynic Acid (Etacrynic Acid)FDA Link
12/2012
1Glutathione Transferase (Glutathione S-Transferase)IBA
12/2012
1Surface Antigens (Surface Antigen)IBA
11/2012
1LipidsIBA
11/2012
1Cyclin EIBA
06/2011
1Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2011
1Bexarotene (LGD1069)FDA Link
06/2011
1MicroRNAs (MicroRNA)IBA
05/2011
1Fulvestrant (Faslodex)FDA Link
04/2011
1CollagenIBA
02/2011
1Epithelial Cell Adhesion MoleculeIBA
02/2011
1Mucin-1 (CA 15-3 Antigen)IBA
02/2011
1Mitochondrial DNA (mtDNA)IBA
02/2011
1Cadherins (E-Cadherin)IBA
06/2010
1Estrogen Receptor alphaIBA
06/2010
1Oncogene Proteins (Oncogene Protein)IBA
03/2009
1AEE 788 (AEE788)IBA
12/2008
1Sirolimus (Rapamycin)FDA Link
12/2008
1Small Interfering RNA (siRNA)IBA
12/2008
1EverolimusFDA Link
12/2008

Therapy/Procedure

21Therapeutics
04/2022 - 01/2002
7Drug Therapy (Chemotherapy)
06/2011 - 01/2002
1Ligation
11/2012